Ontology highlight
ABSTRACT: Background
Xeroderma pigmentosum (XP) is a rare, genetically heterogeneous, autosomal recessive disorder caused by defects in the genes involved in repairing DNA damaged by ultraviolet radiation. These defects lead to a propensity to develop skin cancer at early ages as a hallmark, and progressive neurological degeneration can be observed in around 25% of patients. Eight clinically heterogeneous groups have been identified so far (XPA to XPG and XPV). Xeroderma pigmentosum variant type (XPV) is associated with pathogenic variants in POLH on chromosome 6, and no neurological dysfunction has been seen in these cases. However, on the same chromosome, it has been shown that TREM2 is associated with some types of dementia, particularly in patients with a behavioral variant frontotemporal phenotype.Methods
Gene mutational analysis was performed by whole-exome sequencing.Results
We report a case of a Caucasian woman with XP that developed behavioral and cognitive impairment at age 37. Whole-exome sequencing identified novel homozygous variants in POLH c.638C>G (p.Ser213*) and TREM2 c.154C>T (p.Arg52Cys), classifying the patient as XPV and suggesting that her frontotemporal dementia phenotype could be related to the variant in TREM2.Conclusion
This paper describes a rare case of a patient with two novel variants in the same chromosome associated with XPV and early-onset dementia.
SUBMITTER: Soares IFZ
PROVIDER: S-EPMC7667349 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature
Soares Izadora Fonseca Zaiden IFZ Christofolini Denise Maria DM Silva Lis Gomes LG Feder David D de Siqueira Carvalho Alzira Alves AA
Molecular genetics & genomic medicine 20200916 11
<h4>Background</h4>Xeroderma pigmentosum (XP) is a rare, genetically heterogeneous, autosomal recessive disorder caused by defects in the genes involved in repairing DNA damaged by ultraviolet radiation. These defects lead to a propensity to develop skin cancer at early ages as a hallmark, and progressive neurological degeneration can be observed in around 25% of patients. Eight clinically heterogeneous groups have been identified so far (XPA to XPG and XPV). Xeroderma pigmentosum variant type ( ...[more]